Pregled bibliografske jedinice broj: 162693
Marked improvement in survival following AIDS after introduction of highly active antiretroviral therapy (HAART) in adult patients from Croatia
Marked improvement in survival following AIDS after introduction of highly active antiretroviral therapy (HAART) in adult patients from Croatia // The XV International AIDS Conference
Bangkok, Tajland, 2004. (poster, nije recenziran, sažetak, znanstveni)
CROSBI ID: 162693 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Marked improvement in survival following AIDS after introduction of highly active antiretroviral therapy (HAART) in adult patients from Croatia
Autori
Begovac, J ; Lisić, M: Skerlev, M
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
The XV International AIDS Conference
/ - , 2004
Skup
The XV International AIDS Conference
Mjesto i datum
Bangkok, Tajland, 11.07.2004. - 16.07.2004
Vrsta sudjelovanja
Poster
Vrsta recenzije
Nije recenziran
Ključne riječi
AIDS; HAART
Sažetak
Background: Croatia is a South-Eastern European developing country with a low level HIV-epidemic and a centralized system of care for HIV/AIDS, so all patients are treated at one institution. The aim of this study was to compare the survival of patients after AIDS in the pre-HAART era 1986-1996 to the early HAART era 1997-2000. Methods: In this cohort study data were collected retrospectively up to 1998 and prospectively thereafter. Each patient was considered as a censored observation at the time of last contact if lost to follow-up or known to be alive on Dec 31, 2002. Survival times were calculated using the Kaplan-Meier (KM) method. Cox's proportional hazards model was used to examine factors associated with survival. Different survival periods were modeled, according to the log-minus-log survival plot, for the categories of CD4+ cell count and HAART era. Results: Of 144 patients (88 from pre-HAART and 56 from HAART era) 90 died ; 72 (81.8%) and 18 (32.1%) respectively. 17/88, 19.3%, and 48/56, 85.7%, of patients received HAART, respective to study eras. The 1- and 5-year survival probabilities in the pre-HAART era were 52.1% and 15.4% whereas in the HAART era they were 72.8% and 61.9% respectively. In multivariable analysis survival after 6 months was lower for patients in the HAART era (Hazard Ratio [HR] 0.11 ; 95% CI, 0.04-0.29, p<0.0001) compared to the pre-HAART era. A CD4+ cell count of < 100/mm3 was an independed risk factor for patients surviving up to 2 years (HR 2.14 ; 95% CI, 1.2-3.77, p=0.009), afterward it was not (HR 1.04, 95% CI 0.32-3.34, p=0.95). Patients with tuberculosis/fungal infections had a better survival when compared to other diagnosis (HR 0.46, 95% CI 0.27-0.77, p=0.003). PCP prophylaxis did not reach significance (HR ; 0.62 ; 95% CI 0.36-1.05, p=0.07). Conclusion: Survival after AIDS has markedly improved after introduction of HAART in Croatia. The 1-year probability of death after AIDS was still high in the early HAART era.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA